Displaying 691–700 of 704 results
May 30, 2012
Brooke James has had more than a glimpse of what it means to be blind in certain parts of the world. And she can assure you, it’s scary.
May 3, 2012
While it may not seem obvious, the FDA ultimately drives everything — the researchers and the money. That’s because without FDA approval, you have no treatment, even if you have great research and adequate funding.
Apr 12, 2012
The parents of young children affected by retinal diseases walk a fine line – between making the best of a trying situation and preparing for the worst.
Apr 11, 2012
A quick primer on genes and their critical role in building proteins.
Mar 28, 2012
Because measuring changes is not always easy, people in clinical trials often undergo a number of different tests over one or several years. It can be challenging for the patient, but is necessary to determine if a treatment is working.
Mar 21, 2012
Dr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
Mar 19, 2012
When it comes to describing Eric Fulton, “gregarious” is a more-than-appropriate adjective for the husband and father of two who, fittingly, is also communications manager at the Bethesda-based Clark Construction Group. “It comes naturally to me,” he says of his ability to mix it up with people. “The cause makes it easier. But, otherwise, I’m pretty outgoing; I like to talk to people. It’s what I do.”
Mar 2, 2012
MitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
Feb 9, 2012
What you need to know (and what to expect) about clinical trials.
Oct 4, 2011
A Foundation-funded research group is developing a gene therapy that revives degenerating cones, enabling them to regain their ability to respond to light and provide vision.